Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.
Wang M, Liu AD, Niu Q, Feng X, Zheng YY, Chen SJ, Xu H, Li Q, Hou GQ, Bi XY, Lu YZ, Cheng PP, Liang LM, Jiang YH, Zhao LQ, Liu F, Song LJ, Zhou LL, Xiao LY, Chen F, Li SS, Ma WL, Cao X, Ye H.
Wang M, et al.
Theranostics. 2022 May 26;12(10):4513-4535. doi: 10.7150/thno.72269. eCollection 2022.
Theranostics. 2022.
PMID: 35832075
Free PMC article.